Broadwater Capital’s GSK GSK Stock Holding History

Broadwater Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$14.5K	Hold	300	–	–	0.01%	141
2026 Q2	$15.7K	Hold	300	–	–	0.01%	139
2026 Q1	$14.7K	Hold	300	–	–	0.01%	142
2025 Q4	$14.7K	Hold	300	–	–	0.01%	142
2025 Q3	$12.9K	Sell	300 -11,220	-97%	-$438K	0.01%	153
2025 Q2	$11.5K	Buy	11,520 +11,220	+3,740%	+$429K	0.01%	157
2025 Q1	$11.6K	Hold	300	–	–	0.01%	157
2024 Q4	$10.1K	Hold	300	–	–	0.01%	169
2024 Q3	$12.3K	Hold	300	–	–	0.01%	165
2024 Q2	$11.6K	Hold	300	–	–	0.01%	167
2024 Q1	$12.9K	Hold	300	–	–	0.01%	161
2023 Q4	$11.1K	Buy	+300	New	+$10.8K	0.01%	166

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Equity Investment Corp Atlanta, Georgia $5.3B AUM 8.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Broadwater Capital's GSK Position: Q3 2026 in Review

Broadwater Capital held its GSK (GSK) position steady in Q3 2026 at 300 shares worth $14.5K. The position accounts for 0.01% of the portfolio, ranked #141.

Broadwater Capital first reported a position in GSK in Q4 2023 and has held it in 12 quarters since. The position peaked at $15.7K in Q2 2026. 748 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

Broadwater Capital held 300 shares of GSK worth $14.5K as of Q3 2026.
Broadwater Capital left its GSK share count unchanged in Q3 2026.
GSK made up 0.01% of Broadwater Capital's portfolio in Q3 2026, its #141 holding.
Broadwater Capital first reported a position in GSK in Q4 2023 and has held it in 12 quarters since.
Broadwater Capital's GSK position peaked at $15.7K in Q2 2026.
748 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Broadwater Capital's 13F filing for Q3 2026, filed 12 Nov 2026.